These compounds were also tested on the breast cancer (BC) cell line MDA-MB-231, characterized as a triple-negative/basal-B mammary invasive ductal adenocarcinoma, and the BC cell line BT-549, which is a triple-negative/basal-B mammary papillary invasive ductal carcinoma, and a mucin producer type. Here, MUC5AC is linked to breast cancer.